相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation
Stefan O. Ciurea et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Francesca Patriarca et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Choosing between stem cell therapy and drugs in myelofibrosis
N. Kroeger et al.
LEUKEMIA (2008)
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis
Nicolaus Kroeger et al.
EXPERIMENTAL HEMATOLOGY (2007)
Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis
David S. Snyder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens
Mats Merup et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Palliative goals, patient selection, and perioperative platelet management - Outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic
Ruben A. Mesa et al.
CANCER (2006)
Allogeneic hematopoietic stern-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
D Rondelli et al.
BLOOD (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial
M Marchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
M Ditschkowski et al.
BONE MARROW TRANSPLANTATION (2004)
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
HJ Deeg et al.
BLOOD (2003)
Stem cell transplantation for myelofibrosis: a report from two Canadian centers
A Daly et al.
BONE MARROW TRANSPLANTATION (2003)
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
RA Mesa et al.
BLOOD (2003)
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
J Hessling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
SM Devine et al.
BLOOD (2002)
Splenectomy and hemopoietic stem cell transplantation for myelofibrosis
ZH Li et al.
BLOOD (2001)
Biology and management of idiopathic myelofibrosis
BD Smith et al.
CURRENT OPINION IN ONCOLOGY (2001)
Medical progress: Myelofibrosis with myeloid metaplasia.
A Tefferi
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
